Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma
Public ClinicalTrials.gov record NCT01225315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Placebo-controlled, Parallel-group Study to Establish Proof-of-concept and Explore the Efficacy of Different Doses of ACT-129968 in Adult Patients With Partly Controlled Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only.
Study identification
- NCT ID
- NCT01225315
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 438 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Dec 31, 2011
- Completion
- Jan 31, 2012
- Last update posted
- Jul 8, 2018
2010 – 2012
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Investigative Site # 6204 | Los Angeles | California | 90025 | — |
| Clinical Investigative Site 6208 | Los Angeles | California | 90095 | — |
| Clinical Investigative Site # 6219 | Tallahassee | Florida | 32308 | — |
| Clinical Investigative Site 6213 | Normal | Illinois | 61761 | — |
| Clinical Investigative Site # 6215 | New Orleans | Louisiana | 70112 | — |
| Clinical Investigative Site # 6211 | North Dartmouth | Massachusetts | 02747 | — |
| Clinical Investigative Site # 6209 | St Louis | Missouri | 63141 | — |
| Clinical Investigative Site 6205 | The Bronx | New York | 10461 | — |
| Clinical Investigative Site # 6223 | Winston-Salem | North Carolina | 27157 | — |
| Clinical Inverstigative Site #6201 | Lake Oswego | Oregon | 97035 | — |
| Clinical Investigative Site # 6207 | Medford | Oregon | 97504 | — |
| Clinical Investigative Site # 6214 | Portland | Oregon | 97213 | — |
| Clinical Investigative Site 6203 | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Investigative Site # 6228 | Greenville | South Carolina | 29615 | — |
| Clinical Investigative Site 6230 | Spartanburg | South Carolina | 29303 | — |
| Clinical Investigative Site 6202 | Knoxville | Tennessee | 37909 | — |
| Clinical Investigative Site 6226 | Nashville | Tennessee | 37208 | — |
| Clinical Investigative Site # 6220 | El Paso | Texas | 79903 | — |
| Clinical Investigative Site # 6225 | Fort Worth | Texas | 76132 | — |
| Clinical Investigative Site # 6222 | San Antonio | Texas | 78229 | — |
| Clinical Investigative Site 6229 | San Antonio | Texas | 78229 | — |
| Clinical Investigative Site # 6217 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01225315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2018 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01225315 live on ClinicalTrials.gov.